Quarterly Results • Search Archive

Rubicon Research Limited
Results, Financials & Updates

Follow Rubicon Research Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

1 published deep dive 1 quarter 1 sector

Company Overview

Rubicon Research Limited: latest results and financials

Latest covered quarterQ1 FY27NSE: RUBICON
Revenue from operations₹534.34 CrReported in the latest covered quarter
Profit after tax₹84.78 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

Rubicon Research Limited is an R&D-driven pharmaceutical formulations manufacturing and marketing company focused on regulated markets, particularly the United States and India. The company specializes in complex generics, drug-device combinations (such as nasal sprays), and branded formulations, backed by a wide commercial portfolio including active ANDAs and NDAs.

← All quarterly results

Quarter history

Rubicon Research Limited Results & Financials

Latest Nivata coverage: Q1 FY27 · revenue ₹534.34 Cr · PAT ₹84.78 Cr.

Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.